pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2011-0-2-41-48pulmo-271Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESАвдеевС. Н.AvdeevS. N.

д. м. н., проф., руководитель клинического отдела 

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел. / факс: (495)465-52-64

д. м. н., проф., руководитель клинического отдела

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел. / факс: (495)465-52-64

serg_avdeev@list.ruПоповаК. А.PopovaK. A.

к. м. н., научный сотрудник лаборатории интенсивной пульмонологии и дыхательной недостаточности 

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел: (495) 465-74-15

к. м. н., научный сотрудник лаборатории интенсивной пульмонологии и дыхательной недостаточности

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел: (495) 465-74-15

xenia.popova@mail.ruНеклюдоваГ. В.NekludovaG. V.

д. м. н., ведущий научный сотрудник лаборатории функциональных методов исследования 

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел.: (495) 465-53-84

д. м. н., ведущий научный сотрудник лаборатории функциональных методов исследования

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел.: (495) 465-53-84

nekludova_gala@mail.ruЧучалинА. Г.ChuchalinA. G.

д. м. н., акад., проф., директор 

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел. / факс: (495) 465-52-64

д. м. н., акад., проф., директор

105077, Москва, ул. 11-я Парковая, 32, к. 4

тел. / факс: (495) 465-52-64

chuchalin@inbox.ruФГУ "НИИ пульмонологии" ФМБА РоссииРоссияФГУ "НИИ пульмонологии" ФМБА РоссииRussian Federation201128042011024148Copyright © Авдеев С.Н., Попова К.А., Неклюдова Г.В., Чучалин А.Г., 20112011Авдеев С.Н., Попова К.А., Неклюдова Г.В., Чучалин А.Г.Avdeev S.N., Popova K.A., Nekludova G.V., Chuchalin A.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/271ReferencesМареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. (от Общества специалистов по СН и секции по СН ВНОК). Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (3-й пересмотр). Сердеч. недостат. 2010; 11 (1): 3–62.Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др. (от Общества специалистов по СН и секции по СН ВНОК). Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (3-й пересмотр). Сердеч. недостат. 2010; 11 (1): 3–62.Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследованияЭПОХА-О-ХСН). Сердеч. недостат. 2004; 5 (1): 4–7.Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследованияЭПОХА-О-ХСН). Сердеч. недостат. 2004; 5 (1): 4–7.Беленков Ю.Н., Мареев В.Ю. Агеев Ф.Т., Даниелян М.О.Эпидемиологическое обследование больных ХСН в реальной практике (по обращаемости) ЭПОХА-О-ХСН.От имени рабочей группы "Общества специалистов по сердечной недостаточности". Сердеч. недостат. 2003;4 (3): 116–120.Беленков Ю.Н., Мареев В.Ю. Агеев Ф.Т., Даниелян М.О.Эпидемиологическое обследование больных ХСН в реальной практике (по обращаемости) ЭПОХА-О-ХСН.От имени рабочей группы "Общества специалистов по сердечной недостаточности". Сердеч. недостат. 2003;4 (3): 116–120.McCullough P.A., Philbin E.F., Spertus J.A. et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure(REACH) study. J. Am. Coll. Cardiol. 2002; 39: 60–69.McCullough P.A., Philbin E.F., Spertus J.A. et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure(REACH) study. J. Am. Coll. Cardiol. 2002; 39: 60–69.Redfield M.M. Heart failure – an epidemic of uncertain proportions. N. Engl. J. Med. 2002; 347: 1442–1444.Redfield M.M. Heart failure – an epidemic of uncertain proportions. N. Engl. J. Med. 2002; 347: 1442–1444.Даниелян М.О. Прогноз и лечение хронической сердечной недостаточности (данные 20-летнего наблюдения). Автореф. дис. … канд. мед. наук. М.; 2001.Даниелян М.О. Прогноз и лечение хронической сердечной недостаточности (данные 20-летнего наблюдения). Автореф. дис. … канд. мед. наук. М.; 2001.Lepage S. Acute decompensated heart failure. Can. J.Cardiol. 2008; 24 (Suppl. B): 6B–8B.Lepage S. Acute decompensated heart failure. Can. J.Cardiol. 2008; 24 (Suppl. B): 6B–8B.O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States: Time for a different approach.J. Heart Lung. Transplant 1994; 13: S104–S112.O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States: Time for a different approach.J. Heart Lung. Transplant 1994; 13: S104–S112.Cleland J.G., Swedberg K., Follath F. et al. The EuroHeartFailure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur. Heart J. 2003; 24: 442–463.Cleland J.G., Swedberg K., Follath F. et al. The EuroHeartFailure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur. Heart J. 2003; 24: 442–463.Binanay C., Califf R.M., Hasselblad V. et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. J.A.M.A. 2005; 294:1625–1633.Binanay C., Califf R.M., Hasselblad V. et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. J.A.M.A. 2005; 294:1625–1633.Cuffe M.S., Califf R.M., Adams K.F. Jr. et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J.A.M.A. 2002; 287: 1541–1547.Cuffe M.S., Califf R.M., Adams K.F. Jr. et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J.A.M.A. 2002; 287: 1541–1547.Fonarow G.C., Adams Jr. K.F., Abraham W.T. et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. J.A.M.A. 2005; 293: 572–580.Fonarow G.C., Adams Jr. K.F., Abraham W.T. et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. J.A.M.A. 2005; 293: 572–580.Gheorghiade M., Abraham W.T., Albert N.M. et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.J.A.M.A. 2006; 296: 2217–2226.Gheorghiade M., Abraham W.T., Albert N.M. et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.J.A.M.A. 2006; 296: 2217–2226.Komajda M., Follath F., Swedberg K. et al. The EuroHeartFailure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur. Heart J. 2003; 24: 464–474.Komajda M., Follath F., Swedberg K. et al. The EuroHeartFailure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur. Heart J. 2003; 24: 464–474.Nieminen M.S., Brutsaert D., Dickstein K. et al. EuroHeartFailure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur. Heart J. 2006; 27: 2725–36.Nieminen M.S., Brutsaert D., Dickstein K. et al. EuroHeartFailure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur. Heart J. 2006; 27: 2725–36.Bergh C.-H., Andersson B., Dahlstrom U. et al. Intravenouslevosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Eur. J. Heart Fail. 2010;12: 404–410.Bergh C.-H., Andersson B., Dahlstrom U. et al. Intravenouslevosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Eur. J. Heart Fail. 2010;12: 404–410.Howlett J.G. Current treatment options for early management in acute decompensated heart failure. Can. J. Cardiol.2008; 24 (Suppl. B): 9B–14B.Howlett J.G. Current treatment options for early management in acute decompensated heart failure. Can. J. Cardiol.2008; 24 (Suppl. B): 9B–14B.Joseph S.M., Cedars A.M., Ewald G.A. et al. Acute decompensated heart failure: contemporary medical management.Tex. Heart Inst. J. 2009; 36: 510–520.Joseph S.M., Cedars A.M., Ewald G.A. et al. Acute decompensated heart failure: contemporary medical management.Tex. Heart Inst. J. 2009; 36: 510–520.Chatterjee K. Refractory heart failure – drugs and devices.Eur. Heart J. 2001; 22: 2227–2230.Chatterjee K. Refractory heart failure – drugs and devices.Eur. Heart J. 2001; 22: 2227–2230.Chan C.T. A critical look at acute decompensated heart failure from a nephrologist's perspective. Nephrol. Dial.Transplant 2009; 24: 2024–2026.Chan C.T. A critical look at acute decompensated heart failure from a nephrologist's perspective. Nephrol. Dial.Transplant 2009; 24: 2024–2026.Mehta S., Hill N.S. Noninvasive ventilation. Am. J. Respir.Crit. Care Med. 2001; 163: 540–577.Mehta S., Hill N.S. Noninvasive ventilation. Am. J. Respir.Crit. Care Med. 2001; 163: 540–577.Barach A.L., Martin J., Eckman M. Positive pressure respiration and its application to the treatment of acute pulmonary edema and respiratory obstruction. Proc. Am. Soc.Clin. Invest. 1937; 16: 664–680.Barach A.L., Martin J., Eckman M. Positive pressure respiration and its application to the treatment of acute pulmonary edema and respiratory obstruction. Proc. Am. Soc.Clin. Invest. 1937; 16: 664–680.Poulton E.P., Oxon D.M. Left-sided heart failure with pulmonary oedema: Its treatment with the "pulmonary plus pressure machine." Lancet 1936; 231: 981–983.Poulton E.P., Oxon D.M. Left-sided heart failure with pulmonary oedema: Its treatment with the "pulmonary plus pressure machine." Lancet 1936; 231: 981–983.Rasanen J., Heikkila J., Downs J. et al. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Am. J. Cardiol. 1985; 55: 296–300.Rasanen J., Heikkila J., Downs J. et al. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Am. J. Cardiol. 1985; 55: 296–300.Masip J., Roque M., Sanchez B. et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. Systematic review and meta-analysis. J.A.M.A. 2005; 294: 3124–3130.Masip J., Roque M., Sanchez B. et al. Noninvasive ventilation in acute cardiogenic pulmonary edema. Systematic review and meta-analysis. J.A.M.A. 2005; 294: 3124–3130.Pang D., Keenan S.P., Cook D.J., Sibbald W.J. The effect of positive pressure airway support on mortality and the need for intubation incardiogenic pulmonary edema: a systematic review. Chest 1998; 114: 1185–1192.Pang D., Keenan S.P., Cook D.J., Sibbald W.J. The effect of positive pressure airway support on mortality and the need for intubation incardiogenic pulmonary edema: a systematic review. Chest 1998; 114: 1185–1192.Peters J. Mechanical ventilation with PEEP – a unique therapy for failing hearts. Intensive Care Med. 1999; 25:778–780.Peters J. Mechanical ventilation with PEEP – a unique therapy for failing hearts. Intensive Care Med. 1999; 25:778–780.Bradley T.D., Logan A.G., Kimoff R.J. et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 2005; 353: 2025–2033.Bradley T.D., Logan A.G., Kimoff R.J. et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 2005; 353: 2025–2033.Kaneko Y., Floras J.S., Usui K. et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med. 2003;348: 1233–1241.Kaneko Y., Floras J.S., Usui K. et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med. 2003;348: 1233–1241.Naughton M.T., Rahman M.A., Hara K. et al. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725–1731.Naughton M.T., Rahman M.A., Hara K. et al. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725–1731.Tkacova R., Hall M.J., Liu P.P. et al. Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am. J. Respir. Crit. Care Med. 1997; 156:1549–1555.Tkacova R., Hall M.J., Liu P.P. et al. Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am. J. Respir. Crit. Care Med. 1997; 156:1549–1555.Kaye D.M., Mansfield D., Aggarwal A. et al. Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 2001; 103:2336–2338.Kaye D.M., Mansfield D., Aggarwal A. et al. Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 2001; 103:2336–2338.Spaak J., Egri Z.J., Kubo T. et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005; 46: 1327–1332.Spaak J., Egri Z.J., Kubo T. et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005; 46: 1327–1332.Chen Y., Chen P., Hanaoka M. et al.Mechanical ventilation in patients with hypoxemia due to refractory heart failure.Intern. Med. 2008; 47: 367–373.Chen Y., Chen P., Hanaoka M. et al.Mechanical ventilation in patients with hypoxemia due to refractory heart failure.Intern. Med. 2008; 47: 367–373.Диагностика и лечение острой сердечной недостаточности. Российские рекомендации. http://www.cardiosite.ru/medical/recom-dia.aspДиагностика и лечение острой сердечной недостаточности. Российские рекомендации. http://www.cardiosite.ru/medical/recom-dia.aspDickstein K., Cohen*Solal A., Filippatos G. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 2008; 29: 2388–2442.Dickstein K., Cohen*Solal A., Filippatos G. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 2008; 29: 2388–2442.Jessup M., Abraham W.T., Casey D.E. et al. 2009 focused update: ACCF / AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:1977–2016.Jessup M., Abraham W.T., Casey D.E. et al. 2009 focused update: ACCF / AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:1977–2016.Borg G.A. Psychophysical basis of perceived exertion. Med.Sci. Sports Exerc. 1982; 14: 377–381.Borg G.A. Psychophysical basis of perceived exertion. Med.Sci. Sports Exerc. 1982; 14: 377–381.Black L., Hyatt R. Maximal respiratory pressures: normal values and relationship to age and sex. Am. Rev. Respir. Dis.1969; 99: 696–702.Black L., Hyatt R. Maximal respiratory pressures: normal values and relationship to age and sex. Am. Rev. Respir. Dis.1969; 99: 696–702.Cournand A., Motley H.L., Richards D.W. Physiological studies of the effects of intermittent positive pressure breathing on cardiac output in man. Am. J. Physiol. 1948; 152: 162–174.Cournand A., Motley H.L., Richards D.W. Physiological studies of the effects of intermittent positive pressure breathing on cardiac output in man. Am. J. Physiol. 1948; 152: 162–174.Bellone A., Barbieri A., Ricci C. et al. Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure. Intensive Care Med. 2002; 28: 1348–1350.Bellone A., Barbieri A., Ricci C. et al. Acute effects of non-invasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure. Intensive Care Med. 2002; 28: 1348–1350.Malone S., Liu P.P., Holloway R. et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338:1480–1484.Malone S., Liu P.P., Holloway R. et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338:1480–1484.Willson G.N., Wilcox I., Piper A.J. et al. Treatment of central sleep apnoea in congestive heart failure with nasal ventilation. Thorax 1998; 53 (Suppl. 3): S41–S46.Willson G.N., Wilcox I., Piper A.J. et al. Treatment of central sleep apnoea in congestive heart failure with nasal ventilation. Thorax 1998; 53 (Suppl. 3): S41–S46.Acosta B., DiBenedetto R., Rahimi A. et al. Hemodynamic effects of noninvasive bi-level positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest 2000; 118: 1004–1009.Acosta B., DiBenedetto R., Rahimi A. et al. Hemodynamic effects of noninvasive bi-level positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest 2000; 118: 1004–1009.Sin D.D., Logan A.G., Fitzgerald F.S. et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61–66.Sin D.D., Logan A.G., Fitzgerald F.S. et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61–66.Mansfield D.R., Gollogly N.C., Kaye D.M. et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med.2004; 169: 361–366.Mansfield D.R., Gollogly N.C., Kaye D.M. et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med.2004; 169: 361–366.Arzt M., Schulz M., Wensel R. et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005; 127: 794–802.Arzt M., Schulz M., Wensel R. et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005; 127: 794–802.Bendjelid K., Schutz N., Suter P.M. et al. Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction? Chest 2005; 127: 1053–1058.Bendjelid K., Schutz N., Suter P.M. et al. Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction? Chest 2005; 127: 1053–1058.Noda A., Izawa H., Asano H. et al. Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea hypopnea. A preliminary study.Chest 2007; 131: 1694–1701.Noda A., Izawa H., Asano H. et al. Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea hypopnea. A preliminary study.Chest 2007; 131: 1694–1701.Khayat R.N., Abraham W.T., Patt B. et al. Cardiac effects of continuous and bi level positive airway pressure for patients with heart failure and obstructive sleep apnea. A pilot study.Chest 2008; 134: 1162–1168.Khayat R.N., Abraham W.T., Patt B. et al. Cardiac effects of continuous and bi level positive airway pressure for patients with heart failure and obstructive sleep apnea. A pilot study.Chest 2008; 134: 1162–1168.Keren G., Katz S., Sonnenblick E.H., LeJemtel T.H. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989; 80: 306–313.Keren G., Katz S., Sonnenblick E.H., LeJemtel T.H. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989; 80: 306–313.Bellone A., Etteri M., Vettorello M. et al. The effects of continuous positive airway pressure on plasma brain natriuretic peptide concentrations in patients presenting with acute cardiogenic pulmonary edema with preserved left ventricular systolic function. Am. J. Emerg. Med. 2010; 28: 230–234.Bellone A., Etteri M., Vettorello M. et al. The effects of continuous positive airway pressure on plasma brain natriuretic peptide concentrations in patients presenting with acute cardiogenic pulmonary edema with preserved left ventricular systolic function. Am. J. Emerg. Med. 2010; 28: 230–234.Hosenpud J.D., Stibolt T.A., Atwal K. et al. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am. J. Med. 1990; 88: 493–496.Hosenpud J.D., Stibolt T.A., Atwal K. et al. Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am. J. Med. 1990; 88: 493–496.Wittmer V.L., Simoes G.M.S., Sogame L.C.M., Vasquez E.C.Effects of continuous positive airway pressure on pulmonary function and exercise tolerance in patients with congestive heart failure. Chest 2006; 130: 157–163.Wittmer V.L., Simoes G.M.S., Sogame L.C.M., Vasquez E.C.Effects of continuous positive airway pressure on pulmonary function and exercise tolerance in patients with congestive heart failure. Chest 2006; 130: 157–163.Guazzi M., Marenzi G., Alimento M. et al. Improvement of alveolar capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930–1936.Guazzi M., Marenzi G., Alimento M. et al. Improvement of alveolar capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930–1936.Ambrosino N., Opasich C., Crotti P. et al. Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur. Respir. J. 1994; 7: 17–22.Ambrosino N., Opasich C., Crotti P. et al. Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur. Respir. J. 1994; 7: 17–22.Hammond M.D., Bauer K.A., Sharp J.T., Rocha R.D.Respiratory muscle strength in congestive heart failure.Chest 1990; 98: 1091–1094.Hammond M.D., Bauer K.A., Sharp J.T., Rocha R.D.Respiratory muscle strength in congestive heart failure.Chest 1990; 98: 1091–1094.Braunwald E. Biomarkers in heart failure. N. Engl. J. Med.2008; 358: 2148–2159.Braunwald E. Biomarkers in heart failure. N. Engl. J. Med.2008; 358: 2148–2159.Villacorta H., Masetto A.C., Mesquita E.T. C-Reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. Arq. Bras.Cardiol. 2007; 88: 520–523.Villacorta H., Masetto A.C., Mesquita E.T. C-Reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. Arq. Bras.Cardiol. 2007; 88: 520–523.Kelly C.A., Newby D.E., McDonagh T.A. et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema.Effects on plasma brain natriuretic peptide concentrations.Eur. Heart J. 2002; 23: 1379–1386.Kelly C.A., Newby D.E., McDonagh T.A. et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema.Effects on plasma brain natriuretic peptide concentrations.Eur. Heart J. 2002; 23: 1379–1386.Krauser D., Donald L., Claudia U. et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a Pro BNP investigation of dysphea in the emergency department (PRIDE) substudy. Am.Heart J. 2005; 149: 44–50.Krauser D., Donald L., Claudia U. et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a Pro BNP investigation of dysphea in the emergency department (PRIDE) substudy. Am.Heart J. 2005; 149: 44–50.Dohi T., Kasai T., Narui K. et al. Bi level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ. J. 2008; 72: 1100–1105.Dohi T., Kasai T., Narui K. et al. Bi level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ. J. 2008; 72: 1100–1105.

The authors declare that there are no conflicts of interest present.